Back to top
more

Mesa Laboratories (MLAB)

(Delayed Data from NSDQ)

$118.79 USD

118.79
82,884

-2.00 (-1.66%)

Updated Sep 10, 2024 04:00 PM ET

After-Market: $118.32 -0.47 (-0.40%) 5:08 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value A Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 27% (67 out of 250)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Mesa Labs (MLAB) Gains As Market Dips: What You Should Know

Mesa Labs (MLAB) closed at $193.84 in the latest trading session, marking a +0.96% move from the prior day.

Mesa Labs (MLAB) Outpaces Stock Market Gains: What You Should Know

Mesa Labs (MLAB) closed at $190.51 in the latest trading session, marking a +0.93% move from the prior day.

Is Mesa Laboratories (MLAB) Outperforming Other Medical Stocks This Year?

Here is how Mesa Labs (MLAB) and Cassava Sciences, Inc. (SAVA) have performed compared to their sector so far this year.

Mesa Labs (MLAB) Gains As Market Dips: What You Should Know

Mesa Labs (MLAB) closed the most recent trading day at $178.79, moving +1.53% from the previous trading session.

Here's Why You Should Retain Glaukos (GKOS) in Your Portfolio

Glaukos (GKOS) continues to benefit from a robust product portfolio and favorable clinical trial results.

Here's Why You Should Buy Cardinal Health (CAH) Stock Now

Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment and a diversified product portfolio. However, the cost of products continues to rise.

3 Reasons to Hold DexCom (DXCM) Stock in Your Portfolio (Revised)

Investors continue to be optimistic about DexCom (DXCM) owing to its strong product portfolio.

Here's Why You Should Retain Stryker (SYK) Stock for Now

Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio. However, pricing pressure weighs on it.

3 Reasons to Hold DexCom (DXCM) Stock in Your Portfolio

Investors continue to be optimistic about DexCom (DXCM) owing to its strong product portfolio.

Here's Why You Should Retain PerkinElmer (PKI) Stock Now

PerkinElmer (PKI) continues to gain from a solid product portfolio despite forex woes.

Mesa Labs and Eldorado Gold have been highlighted as Zacks Bull and Bear of the Day

Mesa Labs and Eldorado Gold are part of the Zacks Bull and Bear of the Day article.

Kevin Cook headshot

Bull of the Day: Mesa Labs (MLAB)

After Q2 results, EPS estimates soar 39% as revenues grow 24% on strong M&A strategies

Urmimala Biswas headshot

3 Medical Instruments Stocks to Buy as Inflation Clouds Prospects

The Zacks Medical - Instruments industry is growing on rising demand for digital health. SWAV, MLAB and DYNT are set to gain the most. Yet, the ongoing inflation in the form of rising freight, raw material and labor costs is an overhang.

Earnings Estimates Moving Higher for Mesa Labs (MLAB): Time to Buy?

Mesa Labs (MLAB) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

David Bartosiak headshot

Bear of the Day: Fresenius Medical (FMS)

Profit estimates are moving in the wrong direction.

Mesa Labs (MLAB) Q2 Earnings and Revenues Top Estimates

Mesa Labs (MLAB) delivered earnings and revenue surprises of 107.19% and 10.35%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Mesa Labs (MLAB) Q1 Earnings and Revenues Miss Estimates

Mesa Labs (MLAB) delivered earnings and revenue surprises of -40% and 4.14%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Mesa Labs (MLAB) to Report Q1 Results: Wall Street Expects Earnings Growth

Mesa Labs (MLAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Mesa Labs (MLAB) Surpasses Q4 Earnings and Revenue Estimates

Mesa Labs (MLAB) delivered earnings and revenue surprises of 18.09% and 6.06%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

ReWalk Robotics (RWLK) Reports Q1 Loss, Lags Revenue Estimates

ReWalk (RWLK) delivered earnings and revenue surprises of -40% and 60.18%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

HTG Molecular Diagnostics, Inc. (HTGM) Reports Q1 Loss, Lags Revenue Estimates

HTG Molecular Diagnostics, Inc. (HTGM) delivered earnings and revenue surprises of -14.08% and 15.43%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Mesa Labs (MLAB) Q3 Earnings Miss Estimates

Mesa Labs (MLAB) delivered earnings and revenue surprises of -19.05% and 13.24%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Mesa Labs (MLAB) Earnings Expected to Grow: Should You Buy?

Mesa Labs (MLAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Ideas feature highlights: Edwards Lifesciences, Mesa Laboratories and Sensus Healthcare

Zacks Investment Ideas feature highlights: Edwards Lifesciences, Mesa Laboratories and Sensus Healthcare